Literature DB >> 2469154

Phencyclidine and psychotomimetic sigma opiates: recent insights into their biochemical and physiological sites of action.

M S Sonders, J F Keana, E Weber.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2469154     DOI: 10.1016/0166-2236(88)90048-3

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


× No keyword cloud information.
  17 in total

1.  Near death experience and the NMDA receptor.

Authors:  K Jansen
Journal:  BMJ       Date:  1989-06-24

Review 2.  Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia.

Authors:  C D Nicholson
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 3.  A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: more support for a continuum hypothesis of "functional" psychosis.

Authors:  R F Squires; E Saederup
Journal:  Neurochem Res       Date:  1991-10       Impact factor: 3.996

4.  Similar behavioural effects of sigma agonists and PCP-like non-competitive NMDA antagonists in guinea-pigs.

Authors:  P J Brent
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

5.  Effects of membrane fluidity on [3H]TCP binding to PCP receptors.

Authors:  F R DePietro; J C Byrd
Journal:  J Mol Neurosci       Date:  1990       Impact factor: 3.444

6.  An examination of the putative sigma-receptor in the mouse isolated vas deferens.

Authors:  C Kennedy; G Henderson
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

7.  Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia.

Authors:  Y Noda; K Yamada; H Furukawa; T Nabeshima
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

8.  Sigma receptors in schizophrenic cerebral cortices.

Authors:  H Shibuya; H Mori; M Toru
Journal:  Neurochem Res       Date:  1992-10       Impact factor: 3.996

9.  Pharmacological effects of the non-competitive NMDA antagonist CNS 1102 in normal volunteers.

Authors:  K W Muir; D G Grosset; E Gamzu; K R Lees
Journal:  Br J Clin Pharmacol       Date:  1994-07       Impact factor: 4.335

10.  Identification of the binding subunit of the sigma-type opiate receptor by photoaffinity labeling with 1-(4-azido-2-methyl[6-3H]phenyl)-3-(2-methyl[4,6-3H]phenyl)guanidine.

Authors:  M P Kavanaugh; B C Tester; M W Scherz; J F Keana; E Weber
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.